Valuation: Bonesupport Holding AB

Market Cap 1.66TCr 164.8Cr 148.17Cr 138.27Cr 125.32Cr 235.28Cr 16TCr 236.75Cr 647.95Cr 8.14TCr 618.71Cr 605.31Cr 26TCr P/E 2026 *
52.6x
P/E 2027 * 33x
Enterprise Value 1.61TCr 159.4Cr 143.32Cr 133.75Cr 121.22Cr 227.58Cr 15TCr 229Cr 626.73Cr 7.87TCr 598.45Cr 585.49Cr 25TCr EV / Sales 2026 *
10.7x
EV / Sales 2027 * 7.88x
Free-Float
89.54%
Yield 2026 *
0.58%
Yield 2027 * 0.86%
1 day+25.07%
1 week+21.23%
Current month+17.51%
1 month+21.73%
3 months+15.37%
6 months+5.02%
Current year+43.02%
1 week 234.6
Extreme 234.6
268.4
1 month 207
Extreme 207
268.4
Current year 167.55
Extreme 167.55
272.5
1 year 167.55
Extreme 167.55
272.5
3 years 111.8
Extreme 111.8
404.4
5 years 34.65
Extreme 34.65
404.4
10 years 12.06
Extreme 12.06
404.4
Manager TitleAgeSince
Chief Executive Officer 49 01/09/2025
Director of Finance/CFO 63 01/11/2018
Chief Operating Officer 51 01/12/2021
Director TitleAgeSince
Director/Board Member 68 01/01/2010
Chairman 70 15/12/2016
Chairman 71 14/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+25.07%+21.23% - - 163.61Cr
+3.62%+1.68%+48.80%+98.41% 1,04000Cr
+2.13%-1.76%+33.04%+61.88% 60TCr
+3.32%+4.47%+23.72%+91.59% 48TCr
+3.80%+3.21%+73.99%+41.69% 35TCr
+3.09%+3.03%+29.59%+45.42% 35TCr
+2.82%+2.20%+17.90%+40.15% 27TCr
+3.40%+0.99%-3.44%+12.08% 24TCr
+3.21%+3.15%+45.01%+49.99% 22TCr
+3.80%+4.56%+29.59%+97.73% 18TCr
Average +5.22%+1.90%+33.13%+59.88% 41.59TCr
Weighted average by Cap. +2.67%+1.53%+36.79%+68.68%

Financials

2026 *2027 *
Net sales 149.77Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.42TCr 21Cr 58Cr 734.63Cr 56Cr 55Cr 2.36TCr 199.73Cr 20Cr 18Cr 17Cr 15Cr 28Cr 1.89TCr 28Cr 78Cr 979.66Cr 74Cr 73Cr 3.15TCr
Net income 32Cr 3.18Cr 2.86Cr 2.67Cr 2.42Cr 4.53Cr 302.27Cr 4.56Cr 12Cr 156.88Cr 12Cr 12Cr 504.56Cr 51Cr 5.05Cr 4.54Cr 4.24Cr 3.84Cr 7.21Cr 480.37Cr 7.25Cr 20Cr 249.31Cr 19Cr 19Cr 801.85Cr
Net Debt -54Cr -5.4Cr -4.85Cr -4.53Cr -4.1Cr -7.7Cr -513.47Cr -7.75Cr -21Cr -266.5Cr -20Cr -20Cr -857.12Cr -85Cr -8.44Cr -7.59Cr -7.08Cr -6.42Cr -12Cr -803.19Cr -12Cr -33Cr -416.86Cr -32Cr -31Cr -1.34TCr
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
171
Date Price Change Volume
14/26/14 SEK 254.80 +2.25% 1,70,652
13/26/13 SEK 249.20 +2.98% 48,088
12/26/12 SEK 242.00 +1.94% 14,120
09/26/09 SEK 237.40 +4.31% 19,557
08/26/08 SEK 227.60 +2.80% 62,475
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
253.40SEK
Average target price
356.58SEK
Spread / Average Target
+40.72%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bonesupport Holding AB